Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1775 of 1958 entries
View as:

Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04408924 Org: User:
Start: 01/20/21 End: 06/02/23 Due: 06/02/24

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02597049 Org: User:
Start: 11/30/15 End: 02/28/17 Due: 02/28/18

Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01561430 Org: User:
Start: 03/31/12 End: 08/31/13 Due: 08/31/14

A Study of the Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Substrate) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06165146 Org: User:
Start: 11/10/20 End: 12/30/20 Due: 12/30/21

Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03763604 Org: User:
Start: - End: - Due: -

A Study of LY3053102 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01736241 Org: User:
Start: 12/31/12 End: 07/31/13 Due: 07/31/14

A Study for Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00415194 Org: User:
Start: 12/31/06 End: 03/31/10 Due: 03/31/11

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT04874636 Org: User:
Start: 05/20/21 End: 02/09/22 Due: 02/09/23

Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy Subject

Phase: N/A Priority: Normal
NCT ID: NCT01236105 Org: User:
Start: 10/31/10 End: 12/31/10 Due: 12/31/11

Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes

Phase: N/A Priority: Normal
NCT ID: NCT00192101 Org: User:
Start: 10/31/04 End: 07/31/05 Due: 07/31/06

A Single Dose Study of LY2605541 in Participants With Liver Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01751399 Org: User:
Start: 12/31/12 End: 09/30/13 Due: 09/30/14

Fibromyalgia Health Outcome Study on Cost of Treatments

Phase: N/A Priority: Normal
NCT ID: NCT00725101 Org: User:
Start: 06/30/08 End: 04/30/11 Due: 04/30/12

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05377333 Org: User:
Start: 06/02/22 End: 11/22/23 Due: 11/22/24

ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

Phase: N/A Priority: Normal
NCT ID: NCT00040625 Org: User:
Start: - End: - Due: -

Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock

Phase: N/A Priority: Normal
NCT ID: NCT00604214 Org: User:
Start: 03/31/08 End: 02/29/12 Due: 02/28/13

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Phase: N/A Priority: Normal
NCT ID: NCT06143956 Org: User:
Start: 11/17/23 End: 09/30/26 Due: 09/30/27

A Study for Participants With Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00709995 Org: User:
Start: 06/30/08 End: 09/05/18 Due: 09/05/19

A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT05067270 Org: User:
Start: 10/22/21 End: 12/06/21 Due: 12/06/22

A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00316238 Org: User:
Start: 04/30/06 End: 05/31/07 Due: 05/31/08

A Study of LY2127399 in Participants With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT01205438 Org: User:
Start: 01/31/11 End: 03/31/15 Due: 03/31/16

A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06566170 Org: User:
Start: 10/07/24 End: 05/31/31 Due: 05/31/32

A Phase III Trial For Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00191152 Org: User:
Start: 02/28/02 End: 11/30/08 Due: 11/30/09

A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03115099 Org: User:
Start: 05/31/17 End: 04/05/18 Due: 04/05/19

Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia

Phase: N/A Priority: Normal
NCT ID: NCT01556594 Org: User:
Start: 03/31/12 End: 07/31/12 Due: 07/31/13

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00670319 Org: User:
Start: 11/30/94 End: 09/30/99 Due: 09/30/00